Future research should systematically compare the effects of different agonists, antagonists, and selective AhR modulators (sAhRMs), aiming to screen or design targeted AhR therapies for metabolic diseases that can harness its benefits while mitigating its detrimental effects. The gene discussed is AHR; the disease is Other metabolic disease.